• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

国际儿童和青少年糖尿病学会2024年临床实践共识指南:血糖目标

International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guidelines 2024: Glycemic Targets.

作者信息

de Bock Martin, Agwu Juliana Chizo, Deabreu Matt, Dovc Klemen, Maahs David M, Marcovecchio M Loredana, Mahmud Farid H, Nóvoa-Medina Yeray, Priyambada Leena, Smart Carmel E, DiMeglio Linda A

机构信息

Department of Paediatrics, University of Otago, Christchurch, New Zealand.

Department of Paediatrics, Te Whatu Ora, Waitaha, New Zealand.

出版信息

Horm Res Paediatr. 2024;97(6):546-554. doi: 10.1159/000543266. Epub 2024 Dec 19.

DOI:10.1159/000543266
PMID:39701064
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11854972/
Abstract

The International Society for Pediatric and Adolescent Diabetes (ISPAD) guidelines represent a rich repository that serves as the only comprehensive set of clinical recommendations for children, adolescents, and young adults living with diabetes worldwide. This chapter builds on the 2022 ISPAD guidelines, and updates recommendations on the glycemic targets for children and adolescents living with diabetes. A new target for hemoglobin A1c (HbA1c) of ≤6.5% (48 mmol/mol) is recommended for those who have access to advanced diabetes technologies like continuous glucose monitoring and automated insulin delivery. This target should be encouraged for all children and adolescents living with diabetes when safely achievable. In other settings, the HbA1c target is ≤7.0% (53 mmol/mol). The International Society for Pediatric and Adolescent Diabetes (ISPAD) guidelines represent a rich repository that serves as the only comprehensive set of clinical recommendations for children, adolescents, and young adults living with diabetes worldwide. This chapter builds on the 2022 ISPAD guidelines, and updates recommendations on the glycemic targets for children and adolescents living with diabetes. A new target for hemoglobin A1c (HbA1c) of ≤6.5% (48 mmol/mol) is recommended for those who have access to advanced diabetes technologies like continuous glucose monitoring and automated insulin delivery. This target should be encouraged for all children and adolescents living with diabetes when safely achievable. In other settings, the HbA1c target is ≤7.0% (53 mmol/mol).

摘要

国际儿童和青少年糖尿病协会(ISPAD)指南是一个丰富的知识库,是全球范围内针对患有糖尿病的儿童、青少年和青年的唯一一套全面的临床建议。本章以2022年ISPAD指南为基础,更新了对患有糖尿病的儿童和青少年血糖目标的建议。对于能够使用连续血糖监测和自动胰岛素输送等先进糖尿病技术的患者,建议将糖化血红蛋白(HbA1c)的新目标设定为≤6.5%(48 mmol/mol)。在安全可实现的情况下,应鼓励所有患有糖尿病的儿童和青少年设定这一目标。在其他情况下,HbA1c目标为≤7.0%(53 mmol/mol)。国际儿童和青少年糖尿病协会(ISPAD)指南是一个丰富的知识库,是全球范围内针对患有糖尿病的儿童、青少年和青年的唯一一套全面的临床建议。本章以2022年ISPAD指南为基础,更新了对患有糖尿病的儿童和青少年血糖目标的建议。对于能够使用连续血糖监测和自动胰岛素输送等先进糖尿病技术的患者,建议将糖化血红蛋白(HbA1c)的新目标设定为≤6.5%(48 mmol/mol)。在安全可实现的情况下,应鼓励所有患有糖尿病的儿童和青少年设定这一目标。在其他情况下,HbA1c目标为≤7.0%(53 mmol/mol)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76cc/11854972/fc06eb715d70/hrp-2024-0097-0006-543266_F01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76cc/11854972/fc06eb715d70/hrp-2024-0097-0006-543266_F01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76cc/11854972/fc06eb715d70/hrp-2024-0097-0006-543266_F01.jpg

相似文献

1
International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guidelines 2024: Glycemic Targets.国际儿童和青少年糖尿病学会2024年临床实践共识指南:血糖目标
Horm Res Paediatr. 2024;97(6):546-554. doi: 10.1159/000543266. Epub 2024 Dec 19.
2
International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guidelines 2024 Diabetes Technologies: Glucose Monitoring.国际儿童和青少年糖尿病学会2024年临床实践共识指南:糖尿病技术之血糖监测
Horm Res Paediatr. 2024;97(6):615-635. doi: 10.1159/000543156. Epub 2025 Jan 30.
3
International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guidelines 2024: Diabetes Technologies - Insulin Delivery.国际儿童和青少年糖尿病学会2024年临床实践共识指南:糖尿病技术 - 胰岛素输注
Horm Res Paediatr. 2024;97(6):636-662. doi: 10.1159/000543034. Epub 2024 Dec 10.
4
Above 40% of Polish children and young adults with type 1 diabetes achieve international HbA1c target - results of a nationwide cross-sectional evaluation of glycemic control: The PolPeDiab HbA1c study.超过 40%的波兰 1 型糖尿病儿童和青年达到国际 HbA1c 目标 - 血糖控制的全国性横断面评估结果:波兰儿童和青少年 1 型糖尿病 HbA1c 研究。
Pediatr Diabetes. 2021 Nov;22(7):1003-1013. doi: 10.1111/pedi.13250. Epub 2021 Aug 4.
5
International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guidelines 2024: Insulin and Adjunctive Treatments in Children and Adolescents with Diabetes.国际儿童和青少年糖尿病学会2024年临床实践共识指南:糖尿病儿童和青少年的胰岛素及辅助治疗
Horm Res Paediatr. 2024;97(6):584-614. doi: 10.1159/000543169. Epub 2025 Jan 30.
6
Achieving target levels for vascular risk parameters in Polish school-age children with type 1 diabetes - a single center study.波兰1型糖尿病学龄儿童血管风险参数达标情况——一项单中心研究
J Pediatr Endocrinol Metab. 2018 Oct 25;31(10):1073-1079. doi: 10.1515/jpem-2018-0098.
7
Predictors of glycaemic improvement in children and young adults with type 1 diabetes and very elevated HbA1c using the MiniMed 780G system.使用美敦力780G系统对1型糖尿病且糖化血红蛋白(HbA1c)水平极高的儿童和青年患者血糖改善的预测因素
Diabetes Obes Metab. 2025 Apr;27(4):2138-2146. doi: 10.1111/dom.16210. Epub 2025 Jan 20.
8
Achievement of metabolic control goals set by the American Diabetes Association and the International Society for Pediatric and Adolescent Diabetes in pediatric patients with type 1 diabetes from Spain.西班牙1型糖尿病患儿实现美国糖尿病协会和国际儿童及青少年糖尿病学会设定的代谢控制目标情况。
Diabetes Res Clin Pract. 2015 Feb;107(2):300-5. doi: 10.1016/j.diabres.2014.08.033. Epub 2014 Sep 17.
9
ISPAD Clinical Practice Consensus Guidelines 2018: Glycemic control targets and glucose monitoring for children, adolescents, and young adults with diabetes.国际儿童青少年糖尿病研究学会2018年临床实践共识指南:糖尿病儿童、青少年及青年的血糖控制目标与血糖监测
Pediatr Diabetes. 2018 Oct;19 Suppl 27:105-114. doi: 10.1111/pedi.12737.
10
Treatment regimens and glycaemic outcomes in more than 100 000 children with type 1 diabetes (2013-22): a longitudinal analysis of data from paediatric diabetes registries.10万多名1型糖尿病儿童的治疗方案与血糖结果(2013 - 2022年):来自儿科糖尿病登记处数据的纵向分析
Lancet Diabetes Endocrinol. 2025 Jan;13(1):47-56. doi: 10.1016/S2213-8587(24)00279-1. Epub 2024 Nov 29.

引用本文的文献

1
The effects of diabetes on attention function: a comparative analysis of children and adolescents with type 1 diabetes and their healthy peers.糖尿病对注意力功能的影响:1型糖尿病儿童和青少年与其健康同龄人对比分析
Front Endocrinol (Lausanne). 2025 Aug 12;16:1623539. doi: 10.3389/fendo.2025.1623539. eCollection 2025.
2
Bone Health in Children and Adolescents with Type 1 Diabetes: Optimizing Bone Accrual and Preventing Fractures.1型糖尿病儿童和青少年的骨骼健康:优化骨质积累与预防骨折
Nutrients. 2025 Jul 23;17(15):2400. doi: 10.3390/nu17152400.
3
"SGLT2 Inhibitor-Associated Diabetic Ketoacidosis in a Pediatric Patient: An Off- Label Use Case Report".

本文引用的文献

1
International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guidelines 2024: Diabetes Technologies - Insulin Delivery.国际儿童和青少年糖尿病学会2024年临床实践共识指南:糖尿病技术 - 胰岛素输注
Horm Res Paediatr. 2024;97(6):636-662. doi: 10.1159/000543034. Epub 2024 Dec 10.
2
Prevalence of Chronic Kidney Disease in Type 1 Diabetes Among Adults in the U.S.美国成人 1 型糖尿病患者慢性肾脏病的患病率
Diabetes Care. 2024 Aug 1;47(8):1395-1399. doi: 10.2337/dc24-0335.
3
Early increase in HbA1c trajectory predicts development of severe microangiopathy in patients with type 1 diabetes: the VISS study.
一名儿科患者中与SGLT2抑制剂相关的糖尿病酮症酸中毒:一例超说明书用药病例报告
Int Med Case Rep J. 2025 Aug 6;18:977-983. doi: 10.2147/IMCRJ.S537615. eCollection 2025.
4
Assessment of Microvascular Disturbances in Children with Type 1 Diabetes-A Pilot Study.1型糖尿病患儿微血管病变的评估——一项初步研究
Biosensors (Basel). 2025 Jul 8;15(7):439. doi: 10.3390/bios15070439.
5
Self-Care behaviors and their association with self-efficacy and health literacy among adolescents with type 1 diabetes mellitus in palestine: a cross-sectional study.巴勒斯坦1型糖尿病青少年的自我护理行为及其与自我效能和健康素养的关联:一项横断面研究。
BMC Psychol. 2025 Jul 15;13(1):793. doi: 10.1186/s40359-025-03136-7.
6
Real-world evaluation of safety and efficacy of AHCL systems in young children with type 1 diabetes: a 1-year assessment.1型糖尿病幼儿AHCL系统安全性和有效性的真实世界评估:为期1年的评估
Front Endocrinol (Lausanne). 2025 Jun 26;16:1590964. doi: 10.3389/fendo.2025.1590964. eCollection 2025.
7
The Validation of the Parental Self-Efficacy Scale for Diabetes Management Among Parents of Children Wearing a Continuous Glucose Monitoring Sensor.佩戴持续葡萄糖监测传感器儿童家长糖尿病管理中父母自我效能量表的验证
Biomedicines. 2025 May 27;13(6):1309. doi: 10.3390/biomedicines13061309.
8
Recurrent education: A promising strategy for enhancing diabetes management and reducing hypoglycemia in children with type 1 diabetes.强化教育:一种改善1型糖尿病患儿糖尿病管理及减少低血糖的有效策略。
BMC Endocr Disord. 2025 Apr 21;25(1):109. doi: 10.1186/s12902-025-01917-0.
9
International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guidelines 2024 Diabetes Technologies: Glucose Monitoring.国际儿童和青少年糖尿病学会2024年临床实践共识指南:糖尿病技术之血糖监测
Horm Res Paediatr. 2024;97(6):615-635. doi: 10.1159/000543156. Epub 2025 Jan 30.
HbA1c 轨迹的早期升高可预测 1 型糖尿病患者严重微血管并发症的发生:VISS 研究。
BMJ Open Diabetes Res Care. 2024 May 6;12(3):e003917. doi: 10.1136/bmjdrc-2023-003917.
4
Time in Tight Range for Patients With Type 1 Diabetes: The Time Is Now, or Is It Too Soon?1型糖尿病患者血糖严格控制的时机:是现在,还是为时过早?
Diabetes Care. 2024 May 1;47(5):782-784. doi: 10.2337/dci23-0092.
5
Is It Time to Move Beyond TIR to TITR? Real-World Data from Over 20,000 Users of Continuous Glucose Monitoring in Patients with Type 1 and Type 2 Diabetes.是否是时候超越 TIR 而采用 TITR 了?来自超过 20000 名 1 型和 2 型糖尿病患者使用连续血糖监测的真实世界数据。
Diabetes Technol Ther. 2024 Mar;26(3):203-210. doi: 10.1089/dia.2023.0565.
6
The Health Economics of Automated Insulin Delivery Systems and the Potential Use of Time in Range in Diabetes Modeling: A Narrative Review.自动化胰岛素输送系统的健康经济学和时间范围在糖尿病建模中的潜在应用:叙事性综述。
Diabetes Technol Ther. 2024 Mar;26(S3):66-75. doi: 10.1089/dia.2023.0438.
7
Is It Time to Replace Time-in-Range with Time-in-Tight-Range? Maybe Not.是时候用严格范围内的时间取代血糖范围内的时间了吗?也许并非如此。
Diabetes Technol Ther. 2024 Mar;26(3):147-150. doi: 10.1089/dia.2023.0602.
8
Time in Tight Glucose Range in Type 1 Diabetes: Predictive Factors and Achievable Targets in Real-World Users of the MiniMed 780G System.1 型糖尿病患者的血糖达标时间:美敦力 780G 系统真实世界使用者的预测因素和可实现目标
Diabetes Care. 2024 May 1;47(5):790-797. doi: 10.2337/dc23-1581.
9
14. Children and Adolescents: Standards of Care in Diabetes-2024.14. 儿童和青少年:2024 年糖尿病护理标准。
Diabetes Care. 2024 Jan 1;47(Suppl 1):S258-S281. doi: 10.2337/dc24-S014.
10
Glycemic Control, Basal/Bolus Distribution, BMI and Meal Management in Children and Adolescents with Type 1 Diabetes and Advanced Hybrid Closed Loop.血糖控制、基础/推注分布、BMI 和儿童和青少年 1 型糖尿病及先进混合闭环中的膳食管理。
Nutrients. 2023 Nov 22;15(23):4875. doi: 10.3390/nu15234875.